• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
BNTC

BNTC

Benitec Biopharma Inc.

NASDAQHealthcareBiotechnologyUS

USD10.58

-0.24 (-2.22%)

Rating:C+

Company Profile

CEO

Jerel A. Banks

IPO Date

2014-06-24

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$10.60

Prev. Close

$10.82

Day Low

$10.46

Day High

$11.05

52W Low

$9.85

52W High

$17.15

Market Cap

$0.28B

Volume

0.10M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Insider Trades
FiledInsiderRoleTypeA/DSharesPrice
28 May 2026Friedman David MatthewdirectorA-AwardAcquired35,000$11.45
28 May 2026Friedman David Matthew—Disposed
0
$0.00
26 Jan 2026Mates SharondirectorA-AwardAcquired31,500$12.83
29 Dec 2025SUVRETTA CAPITAL MANAGEMENT, LLCdirector, 10 percent owner:P-PurchaseAcquired42,600$12.85
29 Dec 2025SUVRETTA CAPITAL MANAGEMENT, LLCdirector, 10 percent owner:P-PurchaseAcquired7,400$12.85
29 Dec 2025SUVRETTA CAPITAL MANAGEMENT, LLCdirector, 10 percent owner:P-PurchaseAcquired14,320$13.10
29 Dec 2025SUVRETTA CAPITAL MANAGEMENT, LLCdirector, 10 percent owner:P-PurchaseAcquired2,516$13.10
29 Dec 2025SUVRETTA CAPITAL MANAGEMENT, LLCdirector, 10 percent owner:P-PurchaseAcquired65,800$13.44
29 Dec 2025SUVRETTA CAPITAL MANAGEMENT, LLCdirector, 10 percent owner:P-PurchaseAcquired11,587$13.44
22 Dec 2025SUVRETTA CAPITAL MANAGEMENT, LLCdirector, 10 percent owner:P-PurchaseAcquired8,700$11.24